Table 4 Number of events, median survival time, and 6-month, 1-year, and 2-year survival rates, with 95% confidence intervals in the therapy line before a possible inclusion into the SHERBOC trial

At risk

306

74

306

74

Events

169

18

87

2

Median survival time (months)

11.3 (8.9, 16.1)

–

–

–

6-month survival rate

0.66 (0.61, 0.72)

0.83 (0.74, 0.92)

0.84 (0.80, 0.88)

1.00 (1.00, 1.00)

1-year survival rate

0.48 (0.42, 0.55)

0.76 (0.65, 0.88)

0.72 (0.66, 0.77)

0.96 (0.90, 1.00)

2-year survival rate

0.34 (0.28, 0.41)

0.63 (0.49, 0.82)

0.62 (0.55, 0.69)

0.96 (0.90, 1.00)